Science

We caught up with Carolyn Porter, CEO at CytoSeek. CytoSeek is enabling the next generation of cell therapies through its artificial membrane-binding protein...

We caught up with Guillem Singla, CEO and Co-Founder of Neurofenix as part of ‘Product | People | Potential’. Neurofenix are working on engaging stroke...

We caught up with Neciah Dorh, CEO and Founder of FluoretiQ. FluoretiQ is a rapid bacterial identification technology that can diagnose infection within minu...

We caught up with Gustaf Hemberg, Co-Founder & CEO of Scindo as part of ‘Product | People | Potential’. Scindo is creating a novel biological...

We caught up with Katie Critchlow, CEO of NatureMetrics, as part of ‘Product | People | Potential’. NatureMetrics use next generation sequencing to identify ...

We caught up with Orr Yarkoni, CEO of Colorifix, as part of ‘Product | People | Potential’. Colorifix uses synthetic biology to remove the need...

We caught up with Clarissa Sowemimo-Coker, General Counsel at Oxford Cannabinoid Technologies, and Valentino Parravicini, the Chief Scientific Officer. Oxfor...

We caught up with George Frodsham, CEO of MediSieve, as part of ‘Product | People | Potential’. MediSieve’s goal is to provide doctors with a...

We caught up with Sean Peters, CEO of DryGro, as part of ‘Product | People | Potential’. DryGro is an agriculture technology company working to...

We caught up with Rory Cameron, CEO and Co-Founder of Gendius as part of ‘Product | People | Potential’. Gendius is developing a diabetes pathway...

We caught up with Jolyon Martin, one of the founders of PetMedix, as part of ‘Product | People | Potential’. PetMedix is using the highest...

We caught up with Dr Mark Treherne, Chairman of Talisman Therapeutics as part of ‘Product | People | Potential’. Talisman Therapeutics is committed to revolu...